Obesity

Patel KK, Maddahi J, Agostini D, Bax JJ, Beanlands RSB, Berman D, Dorbala S, Heller GV, Knuuti JM, Pelletier-Galarneau M, Tamaki N, Thompson D, Somer[...]

Sofen HL, Gogineni R, Nishandar T, Bagel J. Efficacy and Safety of Tildrakizumab for Treatment of Moderate-to-Severe Scalp Psoriasis in Patients with Obesity Over 52[...]

Huang K, Huang Y, Zhang Y, Zhang Y, Hatch NW, Freed JK, Cai HL. Endothelial NOX1 Drives Obesity via Skeletal Muscle Mitochondrial Dysfunction. Circ Res.[...]

Lee GJ, Morrell HER, Adams M, Sabaté J, Reboussin DM, Kris-Etherton PM, Petersen KS, Lichtenstein AH, Matthan NR, Li Z, Rajaram S. Effects of one[...]

Cescon E, Goodwin P, Bobrie A, Thezenas S, Ganz T, Nemeth E, Lohmann A, Ennis M, Jacot W, Jerzak KJ. Plasma Hepcidin as a Prognostic[...]

Koo YD, Castillo RT, Sukumaran Nair A, Garneau M, Gochee C, Campbell ZV, Vakil TS, Ha J, Marti A, Soto J, Das D, Martinez-Lopez N,[...]

Shakil SS, Hsue PY. Heart Failure Risk in HIV: From Immunodeficiency to Metabolic Complexity. Circ Heart Fail. 2026 Mar 11:e014088. doi: 10.1161/CIRCHEARTFAILURE.126.014088. Epub ahead of[...]

Siddiqi TJ, Khan MS, Fonarow GC, Butler J, Greene SJ. Reply to commentary on 'effect of glucagon-like peptide-1 receptor agonists on heart failure outcomes and[...]

Schmickl CN, Tripipitsiriwat A, Mokhlesi B, Mallampalli M, Nokes B, Kundel V, Page K, Finch C, Donovan L, Tadros M, Aysola RS, Zinchuk A, Zvenyach[...]

Veliova M, Ferreira CM, Montales KP, Villalobos F, Brownstein AJ, Acín-Pérez R, Ferreira GS, Jones AE, Stiles L, Divakaruni AS, Liesa M, Shirihai OS, Oliveira[...]